The Healthcare of Tomorrow
The healthcare of the future will be ever more digitalized, networked and specialized.
Helios is Europe's leading private hospital operator, with approximately 125,000 employees. Together with Quirónsalud in Spain and Latin America and the Eugin Group with a global network of reproductive clinics, Helios Kliniken in Germany is part of the holding Helios Health. Every year more than 22 million patients choose Helios for medical treatment. In 2021, the company’s sales totaled €10.9 billion.
Helios Germany operates 87 acute care hospitals, about 130 outpatient clinics, six prevention centers and 17 occupational medicine centers. Helios treats approximately 5.4 million patients annually, of whom 4.4 million are outpatients. With more than 75,000 employees, Helios generated sales of €6.7 billion in 2021. Helios is a partner in the "Wir für Gesundheit" hospital network. Helios Germany is headquartered in Berlin.
Quirónsalud operates 56 hospitals, including seven in Latin America, 88 outpatient centers and around 300 occupational risk prevention centers, and treats approximately 17 million patients annually, of whom 16.1 million are outpatients. Quirónsalud has more than 46,000 employees and generated sales of €4 billion in 2021.
Eugin Group’s network comprises 33 clinics and additional 39 sites across 10 countries on 3 continents. With about 1,600 employees, the company offers a wide spectrum of state-of-the-art services in the field of fertility treatments and generated sales of €133 million in 2021.
Fresenius Helios is committed to the highest quality clinical and nursing care. In addition to providing first-class medical care, Helios and Quirónsalud make important contributions to the advancement of medicine. This benefits patients, who can rely on Fresenius Helios hospitals for superior, state-of-the-art treatment and diagnostic procedures.
Key figures (IFRS)
|€ in millions||2021||2020||Growth|
|10,891||9,818||+ 11 %|
|1,127||1,025||+ 10 %|
|728||666||+ 10 %|
Operating cash flow
|1,204||1,149||+ 5 %|
|1,021||1,000||+ 2 %|
R & D expenses
|3||2||+ 50 %|
Employees (December 31)
|123,484||116,952||+ 6 %|
Some figures adjusted for special items
Net income = Net income attributable to shareholders of Fresenius Helios